Scala di valutazione numerica dell’intensita’ del peggior prurito 1,2
| ARGOMENTO | TITOLO |
|---|---|
| Prurito Uremico: impatto sulla QoL | "Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges" --- Shirazian S. et al. International Journal of Nephrology and Renovascular Disease 2017:10 11–26 --- Link |
| Prurito Uremico associato all’emodialisi: percezione dei pazienti | "Self-reported Pruritus and Clinical, Dialysis-Related, and Patient-Reported Outcomes in Hemodialysis Patients" --- Sukul N. et al. Int J Nephrol Renovasc Dis. 2017 Jan 23; 10:11-26 --- Link |
| Relazione tra QoL, rischio di ESRD e mortalità | "Quality of life predicts risks of end-stage renal disease and mortality in patients with chronic kidney disease" --- Tsai Y. et al. Nephrol Dial Transplant (2010) 25: 1621–1626 --- Link |
| Prurito Uremico: linee guida dell’associazione dei dermatologi Britannici sul prurito con capitolo dedicato al Prurito Uremico | "British Association of Dermatologists’ guidelines for the investigation and management of generalized pruritus in adults without an underlying dermatosis, 2018" --- Millington G.W.M. et al. British Journal of Dermatology (2018) 178, pp34–60 --- Link |
| Il prurito severo è un marker di prognosi infausta? | "Etiology and prognostic significance of severe uremic pruritus in chronic hemodialysis patients" --- Narita I. et al. Kidney International (2006) 69, 1626–1632 --- Link |
| Prurito Uremico: indagine sugli outcomes dai dati DOPPS | "Pruritus in haemodialysis patients: international results from the Dialysis Outcomes and Practice Patterns Study (DOPPS)" --- Pisoni R. L. et al. Nephrol Dial Transplant (2006) 21: 3495–3505 --- Link |
| Prurito Uremico: caratteristiche cliniche e sociali | "Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms" --- Ramakrishnan K. et al. International Journal of Nephrology and Renovascular Disease 2014:7 1–12 --- Link |
| PTH come predittore indipendente di fratture, eventi cardiovascolari e morte | "Parathyroid hormone independently predicts fracture, vascular events, and death in patients with stage 3 and 4 chronic kidney disease" --- Geng S. et al. Osteoporosis International (2019) 30: 2019–2025 --- Link |
| KDIGO 2017 CKD-MBD | “Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters” --- Ketteler M. et al. Kidney International (2017) 92, 26–36 --- Link |
| SHPT: le evidenze sembrano appropriate a testare l’idea che i livelli di 25-D tra i 40-50 ng/ml potrebbero essere un trattamento efficace e sicuro per l’SHPT in CKD | “Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low” --- Ennis J.L. et al. J Nephrol (2016) 29:63–70 --- Link |
| SHPT: fisiopatologia alla base del deficit di 25(OH)D e calcitriolo in CKD | “Vitamin D in chronic kidney disease” --- Dusso A. et al. Best Practice & Research Clinical Endocrinology & Metabolism 25 (2011) 647–655 --- Link |
| SHPT: revisione sistematica sulle Vit D attive | “Active vitamin D increases the risk of hypercalcaemia in non-dialysis chronic kidney disease patients with secondary hyperparathyroidism: a systematic review and meta-analysis” --- Cozzolino M. et al. Clinical Kidney Journal, 2021, vol. 14, no. 10, 2437–2443 --- Link |
| SHPT: metabolismo della Vit D in soggetti sani e pazienti CKD | “Effects of Vitamin D2 Supplementation on Vitamin D3 Metabolism in Health and CKD” --- Batacchi Z. et al. Clin J Am Soc Nephrol 12: 1498–1506, 2017 --- Link |
| SHPT: vitamine D nutrizionali in CKD e ESRD: deboli evidenze | “Con: Nutritional vitamin D replacement in chronic kidney disease and end-stage renal disease” ---Agarwal R. et al. Nephrol Dial Transplant (2016) 31: 706–713 --- Link |
Self-reported pruritus and clinical, dialysis-related, patient-reported outcomes in haemodialysis patients
Sukul N, et al. Kidney Medicine. 2020;3(1):42–53.
Clinical characteristics and outcomes of end-stage renal disease patients with self-reported pruritus symptoms
Ramakrishnan K, et al. Int J Nephrol Renovasc Dis. 2014;7:1–12.
International comparisons of prevalence, awareness, and treatment of pruritus in people on haemodialysis
Rayner HC, et al. Clin J Am Soc Nephrol. 2017;12:2000–7
Epidemiology and Causes of CKD-associated Pruritus (CKD-aP) in Dialysis Patients
Backgrounds, Contributing Factors, Consequence and Impact
Entriamo in contatto
Per maggiori e più specifiche informazioni, i rappresentati di Vifor Pharma sono a vostra disposizione
